EUVIMEDEUVIMED entdecken
Open Access

Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients

Laura A Binari iD, Peter Thorne iD, Scott A Rega iD, Irene D Feurer iD, Saed Shawar iD, Ruchi Naik, Kelly A Birdwell iD, J Harold Helderman, Anthony Langone iD, Bonnie Ann Sarrell iD, Heidi Schaefer iD, Bernard John DuBray iD und 5 weitere

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Laura A Binari und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Utilization of hepatitis C viremic (HCV+) deceased donor kidneys (DDKT) for aviremic recipients increases opportunities for transplantation with excellent short‐term outcomes. Our primary aim was to understand longer‐term outcomes, specifically assessing kidney and liver function in the first year posttransplant.

Methods

This was a retrospective single‐center study of adult DDKT recipients of HCV+ kidneys (cases) matched 1:1 to recipients of HCV‐ kidneys (comparators). Between‐group outcomes were analyzed using comparisons of means and proportions, survival analysis methods, and multivariable mixed effects models.

Results

Sixty‐five cases and 65 comparators had statistically comparable demographic and clinical characteristics. There were no between‐group differences in serum creatinine or estimated glomerular filtration rate at month 12 ( p = .662) or in their trajectories over months 1–12 ( p > .292). Within the first 60 days, rates of liver function values >3 times upper limit of normal among cases were comparable to comparators for aspartate aminotransferase (AST) (14% vs. 6%, p = .242) and higher for alanine transaminase (ALT) (23% vs. 6%, p = .011). AST declined during the first 8 weeks ( p = .005) and stabilized for both groups ( p = .406) during the following 10 months. ALT declined during the first 8 weeks ( p < .001), continued to decline over months 3–12 ( p = .016), and the trajectory was unrelated to antiviral therapy initiation among cases.

Conclusions

Aviremic recipients of HCV+ kidneys had comparable kidney outcomes to matched recipients of HCV‐ kidneys. Despite more HCV+ recipients having an elevation in ALT within the first 60 days, ALT values normalized with no identified liver complications attributed to HCV. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHepatitis CAdultHumansRetrospective StudiesAntiviral AgentsKidneyHepacivirusTissue DonorsViremia

Stichwörter der Autor:innen

estimated glomerular filtration ratehepatitis Ckidney transplantliver function

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Division of Nephrology and Hypertension, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota, USA.
  • Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Surgery, Department of Biostatistics, Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Division of Nephrology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Division of Kidney and Pancreas Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Laura A Binari, Peter Thorne, Scott A Rega, Irene D Feurer, Saed Shawar, Kelly A Birdwell, Anthony Langone, Bonnie Ann Sarrell, Heidi Schaefer, Bernard John DuBray, Laura Hickman, David Shaffer, Beatrice P Concepcion, Rachel C Forbes

Förderung

  • NCATS NIH HHS

Zitieren

APA

Binari, L. A., Thorne, P., Rega, S. A., Feurer, I. D., Shawar, S., Naik, R., Birdwell, K. A., Helderman, J. H., Langone, A., Sarrell, B. A., Schaefer, H., DuBray, B. J., Eid, K., Hickman, L., Shaffer, D., Concepcion, B. P., & Forbes, R. C. (2024). Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14213

Vancouver

Binari LA, Thorne P, Rega SA, Feurer ID, Shawar S, Naik R, et al. Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients. Transplant Infectious Disease. 2024. doi:10.1111/tid.14213

BibTeX
@article{Binari2024,
  author = {Binari, Laura A and Thorne, Peter and Rega, Scott A and Feurer, Irene D and Shawar, Saed and Naik, Ruchi and Birdwell, Kelly A and Helderman, J Harold and Langone, Anthony and Sarrell, Bonnie Ann and Schaefer, Heidi and DuBray, Bernard John and Eid, Kareem and Hickman, Laura and Shaffer, David and Concepcion, Beatrice P and Forbes, Rachel C},
  title = {Twelve‐month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14213}
}
Kostenlos starten →